Report Detail
COVID-19 Impact on Global Gene Therapies for Tumor Treatment Market Insights, Forecast to 2026
- RnM4018107 |
- 09 June, 2020 |
- Global |
- 112 Pages |
- QYResearch |
- Chemical & Material
Gene Therapies for Tumor Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapies for Tumor Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Gene Therapies for Tumor Treatment market is segmented into
Gene Induced Immunotherapy
Oncolytic Virotherapy
Gene Transfer
Segment by Application, the Gene Therapies for Tumor Treatment market is segmented into
Hospital
Clinic
Other
Regional and Country-level Analysis
The Gene Therapies for Tumor Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Gene Therapies for Tumor Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Gene Therapies for Tumor Treatment Market Share Analysis
Gene Therapies for Tumor Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gene Therapies for Tumor Treatment business, the date to enter into the Gene Therapies for Tumor Treatment market, Gene Therapies for Tumor Treatment product introduction, recent developments, etc.
The major vendors covered:
Novartis
Kite Pharma
Amgen
Shanghai Sunway
Sibiono
...
1 Study Coverage
- 1.1 Gene Therapies for Tumor Treatment Product Introduction
- 1.2 Market Segments
- 1.3 Key Gene Therapies for Tumor Treatment Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Type
- 1.4.2 Gene Induced Immunotherapy
- 1.4.3 Oncolytic Virotherapy
- 1.4.4 Gene Transfer
- 1.5 Market by Application
- 1.5.1 Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Other
- 1.6 Coronavirus Disease 2019 (Covid-19): Gene Therapies for Tumor Treatment Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Gene Therapies for Tumor Treatment Industry
- 1.6.1.1 Gene Therapies for Tumor Treatment Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Gene Therapies for Tumor Treatment Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Gene Therapies for Tumor Treatment Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Gene Therapies for Tumor Treatment Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Gene Therapies for Tumor Treatment Market Size Estimates and Forecasts
- 2.1.1 Global Gene Therapies for Tumor Treatment Revenue 2015-2026
- 2.1.2 Global Gene Therapies for Tumor Treatment Sales 2015-2026
- 2.2 Gene Therapies for Tumor Treatment Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Gene Therapies for Tumor Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Gene Therapies for Tumor Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Gene Therapies for Tumor Treatment Competitor Landscape by Players
- 3.1 Gene Therapies for Tumor Treatment Sales by Manufacturers
- 3.1.1 Gene Therapies for Tumor Treatment Sales by Manufacturers (2015-2020)
- 3.1.2 Gene Therapies for Tumor Treatment Sales Market Share by Manufacturers (2015-2020)
- 3.2 Gene Therapies for Tumor Treatment Revenue by Manufacturers
- 3.2.1 Gene Therapies for Tumor Treatment Revenue by Manufacturers (2015-2020)
- 3.2.2 Gene Therapies for Tumor Treatment Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Gene Therapies for Tumor Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Gene Therapies for Tumor Treatment Revenue in 2019
- 3.2.5 Global Gene Therapies for Tumor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Gene Therapies for Tumor Treatment Price by Manufacturers
- 3.4 Gene Therapies for Tumor Treatment Manufacturing Base Distribution, Product Types
- 3.4.1 Gene Therapies for Tumor Treatment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Gene Therapies for Tumor Treatment Product Type
- 3.4.3 Date of International Manufacturers Enter into Gene Therapies for Tumor Treatment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Gene Therapies for Tumor Treatment Market Size by Type (2015-2020)
- 4.1.1 Global Gene Therapies for Tumor Treatment Sales by Type (2015-2020)
- 4.1.2 Global Gene Therapies for Tumor Treatment Revenue by Type (2015-2020)
- 4.1.3 Gene Therapies for Tumor Treatment Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Gene Therapies for Tumor Treatment Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Gene Therapies for Tumor Treatment Sales Forecast by Type (2021-2026)
- 4.2.2 Global Gene Therapies for Tumor Treatment Revenue Forecast by Type (2021-2026)
- 4.2.3 Gene Therapies for Tumor Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Gene Therapies for Tumor Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Gene Therapies for Tumor Treatment Market Size by Application (2015-2020)
- 5.1.1 Global Gene Therapies for Tumor Treatment Sales by Application (2015-2020)
- 5.1.2 Global Gene Therapies for Tumor Treatment Revenue by Application (2015-2020)
- 5.1.3 Gene Therapies for Tumor Treatment Price by Application (2015-2020)
- 5.2 Gene Therapies for Tumor Treatment Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Gene Therapies for Tumor Treatment Sales Forecast by Application (2021-2026)
- 5.2.2 Global Gene Therapies for Tumor Treatment Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Gene Therapies for Tumor Treatment Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Gene Therapies for Tumor Treatment by Country
- 6.1.1 North America Gene Therapies for Tumor Treatment Sales by Country
- 6.1.2 North America Gene Therapies for Tumor Treatment Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Gene Therapies for Tumor Treatment Market Facts & Figures by Type
- 6.3 North America Gene Therapies for Tumor Treatment Market Facts & Figures by Application
7 Europe
- 7.1 Europe Gene Therapies for Tumor Treatment by Country
- 7.1.1 Europe Gene Therapies for Tumor Treatment Sales by Country
- 7.1.2 Europe Gene Therapies for Tumor Treatment Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Gene Therapies for Tumor Treatment Market Facts & Figures by Type
- 7.3 Europe Gene Therapies for Tumor Treatment Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Gene Therapies for Tumor Treatment by Region
- 8.1.1 Asia Pacific Gene Therapies for Tumor Treatment Sales by Region
- 8.1.2 Asia Pacific Gene Therapies for Tumor Treatment Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Gene Therapies for Tumor Treatment Market Facts & Figures by Type
- 8.3 Asia Pacific Gene Therapies for Tumor Treatment Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Gene Therapies for Tumor Treatment by Country
- 9.1.1 Latin America Gene Therapies for Tumor Treatment Sales by Country
- 9.1.2 Latin America Gene Therapies for Tumor Treatment Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Gene Therapies for Tumor Treatment Market Facts & Figures by Type
- 9.3 Central & South America Gene Therapies for Tumor Treatment Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Gene Therapies for Tumor Treatment by Country
- 10.1.1 Middle East and Africa Gene Therapies for Tumor Treatment Sales by Country
- 10.1.2 Middle East and Africa Gene Therapies for Tumor Treatment Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Gene Therapies for Tumor Treatment Market Facts & Figures by Type
- 10.3 Middle East and Africa Gene Therapies for Tumor Treatment Market Facts & Figures by Application
11 Company Profiles
- 11.1 Novartis
- 11.1.1 Novartis Corporation Information
- 11.1.2 Novartis Description, Business Overview and Total Revenue
- 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Novartis Gene Therapies for Tumor Treatment Products Offered
- 11.1.5 Novartis Recent Development
- 11.2 Kite Pharma
- 11.2.1 Kite Pharma Corporation Information
- 11.2.2 Kite Pharma Description, Business Overview and Total Revenue
- 11.2.3 Kite Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Kite Pharma Gene Therapies for Tumor Treatment Products Offered
- 11.2.5 Kite Pharma Recent Development
- 11.3 Amgen
- 11.3.1 Amgen Corporation Information
- 11.3.2 Amgen Description, Business Overview and Total Revenue
- 11.3.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Amgen Gene Therapies for Tumor Treatment Products Offered
- 11.3.5 Amgen Recent Development
- 11.4 Shanghai Sunway
- 11.4.1 Shanghai Sunway Corporation Information
- 11.4.2 Shanghai Sunway Description, Business Overview and Total Revenue
- 11.4.3 Shanghai Sunway Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Shanghai Sunway Gene Therapies for Tumor Treatment Products Offered
- 11.4.5 Shanghai Sunway Recent Development
- 11.5 Sibiono
- 11.5.1 Sibiono Corporation Information
- 11.5.2 Sibiono Description, Business Overview and Total Revenue
- 11.5.3 Sibiono Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Sibiono Gene Therapies for Tumor Treatment Products Offered
- 11.5.5 Sibiono Recent Development
- 11.1 Novartis
- 11.1.1 Novartis Corporation Information
- 11.1.2 Novartis Description, Business Overview and Total Revenue
- 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Novartis Gene Therapies for Tumor Treatment Products Offered
- 11.1.5 Novartis Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Gene Therapies for Tumor Treatment Market Estimates and Projections by Region
- 12.1.1 Global Gene Therapies for Tumor Treatment Sales Forecast by Regions 2021-2026
- 12.1.2 Global Gene Therapies for Tumor Treatment Revenue Forecast by Regions 2021-2026
- 12.2 North America Gene Therapies for Tumor Treatment Market Size Forecast (2021-2026)
- 12.2.1 North America: Gene Therapies for Tumor Treatment Sales Forecast (2021-2026)
- 12.2.2 North America: Gene Therapies for Tumor Treatment Revenue Forecast (2021-2026)
- 12.2.3 North America: Gene Therapies for Tumor Treatment Market Size Forecast by Country (2021-2026)
- 12.3 Europe Gene Therapies for Tumor Treatment Market Size Forecast (2021-2026)
- 12.3.1 Europe: Gene Therapies for Tumor Treatment Sales Forecast (2021-2026)
- 12.3.2 Europe: Gene Therapies for Tumor Treatment Revenue Forecast (2021-2026)
- 12.3.3 Europe: Gene Therapies for Tumor Treatment Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Gene Therapies for Tumor Treatment Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Gene Therapies for Tumor Treatment Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Gene Therapies for Tumor Treatment Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Gene Therapies for Tumor Treatment Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Gene Therapies for Tumor Treatment Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Gene Therapies for Tumor Treatment Sales Forecast (2021-2026)
- 12.5.2 Latin America: Gene Therapies for Tumor Treatment Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Gene Therapies for Tumor Treatment Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Gene Therapies for Tumor Treatment Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Gene Therapies for Tumor Treatment Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Gene Therapies for Tumor Treatment Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Gene Therapies for Tumor Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Gene Therapies for Tumor Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Gene Therapies for Tumor Treatment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Gene Therapies for Tumor Treatment. Industry analysis & Market Report on COVID-19 Impact on Global Gene Therapies for Tumor Treatment is a syndicated market report, published as COVID-19 Impact on Global Gene Therapies for Tumor Treatment Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Gene Therapies for Tumor Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
